Holen Sie sich die Stockscreener-App
3.85
3.75%
-0.15
Handel nachbörslich:
3.85
Schlusskurs vom Vortag:
$4.00
Offen:
$3.995
24-Stunden-Volumen:
569.45K
Relative Volume:
0.76
Marktkapitalisierung:
$512.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-18.86M
KGV:
-0.2398
EPS:
-16.054
Netto-Cashflow:
$-17.68M
1W Leistung:
+8.45%
1M Leistung:
+251.60%
6M Leistung:
+118.75%
1J Leistung:
+17.38%
1-Tages-Spanne:
$3.46
$3.995
1-Wochen-Bereich:
$2.90
$4.22
52-Wochen-Spanne:
$0.92
$8.57
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Firmenname
Indaptus Therapeutics Inc
Sektor
Branche
Telefon
(646) 427-2727
Adresse
3 COLUMBUS CIRCLE, NEW YORK
Compare INDP vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDP
Indaptus Therapeutics Inc
|
3.85 | 512.98M | 0 | -18.86M | -17.68M | -16.05 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Indaptus Therapeutics Inc Aktie (INDP) Neueste Nachrichten
Market Movers | Winners: VKTX, INDP, MAZE | Losers: XNDU, EVER, CLDX - Trefis
September 2026's Top Stocks by Monthly Momentum - Stock Titan
Indaptus Therapeutics Announces Private Equity Financing Deal - TipRanks
Indaptus Therapeutics Shares Rise After Entering $24 Million Private Placement - marketscreener.com
Form 8K Indaptus Therapeutics Inc For: 10 September By Investing.com - Investing.com South Africa
Form 8K Indaptus Therapeutics Inc For: 10 September - Investing.com India
Indaptus Therapeutics Raises $24 Million in Private Placement of 20.3M Shares - TradingView
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Indaptus Therapeutics Secures $100 Million At-The-Market Equity Facility - Minichart
Indaptus Therapeutics, Inc. announced that it expects to receive $23.999989 million in funding - marketscreener.com
Indaptus Therapeutics Announces Routine Board Member Resignation - TipRanks
Indaptus Therapeutics, Inc. Announces Resignation of Tim Ruan from Director, Effective September 2, 2026 - marketscreener.com
Indaptus Therapeutics (INDP) updates $100M stock sale plan - Stock Titan
INDP Q4 2025 Earnings: EPS Misses by 1.41% With No Revenue, But Shares Gain 0.88%Earnings Decline Risk - dars.gov.et
Indaptus Updates ATM Agreement to Expand Capital Flexibility - tipranks.com
Indaptus Therapeutics Launches $100 Million ATM Equity Program With H.C. Wainwright - TradingView
Indaptus sets up $100M at-the-market stock program - Stock Titan
Indaptus Therapeutics Launches $100M ATM Offering at $1.14 Per Share (NASDAQ: INDP) - Kalkine Media
Indaptus Therapeutics, Inc. SEC Filing (Aug 26, 2026) - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Indaptus Therapeutics Stock Price Forecast. Should You Buy INDP? - StockInvest.us
Indaptus Therapeutics Inc (NASDAQ: INDP) Share Price, INDP Stock News, INDP Share Price & Updates - Kalkine
Short Interest in Indaptus Therapeutics, Inc. (NASDAQ:INDP) Declines By 64.1% - MarketBeat
Indaptus Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
Indaptus Therapeutics Q2 EPS beats estimate as loss narrows - scanx.trade
Indaptus Therapeutics Reports Q2 Results Amid Strategic Pivot - TipRanks
Indaptus Therapeutics, Inc. 2Q 2026: Net loss $(1.79M), EPS $(0.02) — 10-Q Summary - TradingView
Indaptus Therapeutics (Nasdaq: INDP) cuts losses and raises $12M in Q2 - Stock Titan
Indaptus Q2 Net Loss Narrows to $1.8 Million - Quiver Quantitative
Indaptus Therapeutics (INDP) slashes R&D costs and bolsters cash after $12M raise - Stock Titan
Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Indaptus Therapeutics (INDP) Falls 14% to $1.02 — Biotech Micro-Cap Tests Critical SupportDescending Triangle - vinanet.vn
Indaptus Therapeutics Inc (INDP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Indaptus Therapeutics (INDP) Q4 2025 Earnings: Wider-than-Expected Loss Amid No RevenueReturn On Equity - dars.gov.et
Indaptus Therapeutics (INDP) to Announce Earnings on Monday - MarketBeat
Qinglai Lu Net Worth (2026) - GuruFocus
Indaptus Therapeutics Inc (INDP) Stock News Today - TradingKey
Indaptus Therapeutics (INDP) Slides 10.4% — Approaches Key Support at $1.23Quality ETF - careplusvn.com
Indaptus Therapeutics (INDP) Slides 10.4% as Clinical-Stage Biotech Faces Selling PressureIchimoku Kumo Twist - vinanet.vn
INDP Q4 2025 Earnings: Wider-Than-Expected Loss Sends Shares Down 20.88%Gross Profit Margin - careplusvn.com
Indaptus Therapeutics Inc (INDP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
INDP|Indaptus Therapeutics Inc|Price:2.610|Chg%:-0.160 - TradingKey
Indaptus Therapeutics Inc (INDP) Balance Sheet - TradingKey
Indaptus Therapeutics (INDP) Plunges 21% – Key Support Levels in FocusMFI Divergence - vinanet.vn
Indaptus Therapeutics Inc (INDP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Indaptus Therapeutics Inc (INDP) Cash Flow - TradingKey
Indaptus Therapeutics Market Sentiment - Benzinga España
Indaptus Therapeutics Inc (INDP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Indaptus Therapeutics Inc (INDP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
INDP|Indaptus Therapeutics Inc|Price:2.060|Chg%:-0.550 - TradingKey
Indaptus Therapeutics, Inc. Revenue Breakdown – NASDAQ:INDP - TradingView
Finanzdaten der Indaptus Therapeutics Inc-Aktie (INDP)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):